12 Best Household Stocks to Buy According to Hedge Funds

Page 7 of 11

5. Kenvue Inc. (NYSE:KVUE)

Number of Hedge Fund Holders: 38

Kenvue Inc. (NYSE:KVUE) is a consumer health company that operates through three segments: Skin Health and Beauty, Self Care, and Essential Health. Its Skin Health and Beauty segment offers hair care, body care, face care, and other product categories. The Essential Health segment comprises baby care, women’s health, oral care, and more. The company’s global footprint spans more than 165 countries across its four regions.

The company reported adjusted earnings per share (EPS) of $0.26 in fiscal Q4 2024, in line with analyst expectations. Although the company faced some headwinds, it managed to improve its operating income margins and gross profit year-over-year, reflecting operational efficiency gains.

Kenvue Inc. (NYSE:KVUE) owns popular brands such as Tylenol and Listerine and maintains its competitive edge through continuous innovation and strong brand recognition. It has recently focused on improving its brand investments and implementing operational efficiencies to boost growth.

The company operates globally, and its relationship with Johnson & Johnson, its parent company, reinforces its market standing by supporting its research capabilities and supply chain. On March 5, Canaccord raised Kenvue Inc.’s (NYSE:KVUE) price target to $29 from $24, keeping a Buy rating on the shares. The firm raised its price target because of the strong cold/flu season, as the increased illness incidence rates for cough/cold/flu may lead to an unplanned replenishment opportunity.

Page 7 of 11